L-dopa and somatotropin secretion in humans
Giordano, G.; Marugo, M.; Minuto, F.; Barreca, T.; Foppiani, E.
Folia Endocrinologica 26(6): 523-537
1973
ISSN/ISBN: 0015-5535 PMID: 4801262 Document Number: 60387
Document emailed within 1 workday
Related Documents
Petralito, A.; Lunetta, M.; Fiore, C.E.; Liuzzo, A.; Giuga, G. 1978: Influence of verapamil on blood sugar and insulin secretion after intravenous administration of glucose and on somatotropin secretion after insulin stimulation Bollettino Della Societa Italiana di Cardiologia 23(2): 404-411Protich, M.; Petkova, M.; Tsanev, A. 1989: The diagnostic value of the propranolol-glucagon test for somatotropin secretion Vutreshni Bolesti 28(4): 70-72
Cavagnini, F.; Pontiroli, A.E.; Raggi, U.; Peracchi, M.; Malinverni, A. 1973: Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion Folia Endocrinologica 26(6): 483-489
Murialdo, G.; Calzia, R.; Piscopo, R.; Zauli, C.; Giovale, M.; Santoni, O. 1982: Evaluation of pituitary functional periodicity by harmonic analysis. I) Circadian somatotropin secretion in acromegaly Bollettino della Societa Italiana di Biologia Sperimentale 58(9): 532-538
Rochiccioli, P.; Enjaume, C.; Tauber, M.T.; Pienkowski, C.; Oliver, I. 1993: Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient Annales de Pediatrie 40(7): 391-395
Slavnov, V.N.; Epshteĭn, E.V.; Efimov, A.S.; Luchitskiĭ, E.V. 1981: Relation between blood somatostatin concentration and somatotropin, insulin and glucagon secretion in endocrine diseases Problemy Endokrinologii 27(2): 3-6
Bertolini, S.; Elicio, N.; Costa, S.; Balestreri, R. 1975: Disulfiram and inhibition by L-dopa of the hypothalamo-hypophyseal-adrenocortical system during hypoglycemic stress in humans Bollettino della Societa Italiana di Biologia Sperimentale 51(4): 184-188
Pombo, M.; Paz, M. 1976: Potentialization of the action of tl-dopa on the secretion of growth hormone Archives Francaises de Pediatrie 33(7): 714-715
Fatranská, M.; Jurcovicová, J.; Németh, S.; Vigas, M. 1988: Diminished growth hormone secretion in blind males after L-dopa stimulation Endocrinologia Experimentalis 22(4): 243-248
Casanueva, F.; Villanueva, L.; Peñalva, A.; Rodríguez, R.; Vila, T.; Cabezas-Cerrato, J. 1979: Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa Revista Clinica Espanola 153(3): 217-220
Rochiccioli, P.; Enjeaume, P.; Dutau, G.; Ribot, C.; Augier, D. 1976: Stimulation by the propranolol-glucagon test of somatotropin secretion in 71 children. Results, statistical study and comparison with the insulin-arginine test Archives Francaises de Pediatrie 33(5): 453-465
Trusov, V.V.; Kazakova, I.A.; Nasachev, A.A. 1986: Characteristics of carbohydrate metabolic disorders and of the secretion of insulin, glucagon and somatotropin in patients with chronic glomerulonephritis and chronic kidney failure Terapevticheskii Arkhiv 58(8): 13-18
Frauch, P. 1978: Lacrimal gland secretion and precorneal film in healthy humans Pharmaceutica Acta Helvetiae 53(1): 1-16
Guslandi, M.; Tittobello, A. 1991: Sustained enhancement of gastric HCO3 secretion in humans by enprostil Therapie 46(1): 13-15
Sarosiek, J.; Hetzel, D.P.; Yu, Z.; Piascik, R.; Li, L.; Rourk, R.M.; McCallum, R.W. 1993: Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans American Journal of Gastroenterology 88(7): 1081-1087
Arakawa, M.; Uchida, N.; Kanda, N.; Kurosawa, Y.; Odani, T.; Kanmatsuse, K.; Endo, M.; Yamazaki, T.; Hidaka, S. 2014: Influence of losartan intake on the circadian rhythm of melatonin secretion in humans Die Pharmazie 69(3): 192-197
Bergonzi, P.; Chiurulla, C.; Gambi, D.; Mennuni, G.; Pinto, F. 1975: L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment Acta Neurologica Belgica 75(1): 5-10
Bizzarri, B.Mattia.; Tortolini, S.; Rotelli, L.; Botta, G.; Saladino, R. 2015: Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity Current Medicinal Chemistry 22(36): 4138-4165
Hansson, C.; Rorsman, H.; Rosengren, E. 1981: Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid Acta Dermato-Venereologica 61(2): 147-148
Guillard, A. 1972: Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor Bruxelles Medical 52(10): 673-680